✦ LIBER ✦

PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Korea

✍ Scribed by Oh, J.J.; Shin, H.H.; Jung, H.; Park, J.H.; Ko, S.K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Fondaparinux versus enoxaparin for preve

✍ Edward Morris 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 92 KB

Fondaparinux versus enoxaparin for preve

✍ Heinrich Thaler; Ernst Sim 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 49 KB

Fondaparinux versus enoxaparin for preve

✍ Javier Borja; Pere Olivella; Jorge Curto 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 57 KB

Fondaparinux versus enoxaparin for preve

✍ MR Lassen; AGG Turpie 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 46 KB